Navigation Links
Optimer Pharmaceuticals' Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
Date:2/27/2013

until his retirement in February 2007, Dr. McKinnell was associated with Pfizer Inc., including serving as Pfizer's Chief Executive Officer from January 2001 to July 2006 and Chairman of its Board from May 2001 until December 2006. Dr. McKinnell currently serves as the Chairman of the Board of Moody's Corporation and Chairman of the Board of the Accordia Global Health Foundation.  He is Chairman Emeritus of the Connecticut Science Center and is a member of the Academic Alliance for AIDS Care and Prevention in Africa. Dr. McKinnell previously served as director of ExxonMobil Corporation from 2002 to 2007 and John Wiley & Sons from 1996 to 2005. Dr. McKinnell holds a Bachelor's Degree in business from the University of British Columbia, and M.B.A. and Ph.D. degrees from the Stanford University Graduate School of Business.

About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed DIFICID (fidaxomicin) tablets, an FDA-approved macrolide antibacterial drug for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older and is commercializing DIFICID in the U.S. and Canada. Optimer also received marketing authorization for fidaxomicin tablets in the European Union, where its partner, Astellas Pharma Europe, is commercializing fidaxomicin under the trade name DIFICLIR™. The Company is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem. Additional information can be found at http://www.optimerpharma.com.

Forward-looking Statements
Statements included in this press release that are not a description of historical facts are forward-looking statem
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
2. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
3. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
4. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
5. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
6. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
7. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
8. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
9. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
10. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ... to report its second quarter 2014 financial results on ... Dr. J. Joseph Kim and CFO ... a corporate update, and participate in a live Q&A ... for VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers ...
(Date:7/31/2014)... , Indien, August 1, 2014 ... BioQuiddity Inc. gaben heute bekannt, vor kurzem ... Anästhesieanwendungen zur Schmerzbehandlung nach chirurgischen Eingriffen eine ... Gebiet der Europäischen Union und weiterer europäischer ... versehene und mit Ropivacain gefüllte OneDose ReadyfusOR ...
(Date:7/31/2014)... Calif., July 31, 2014 IRIDEX Corporation (Nasdaq: ... quarter and six months ended June 28, 2014.  ... 2014, up 15% from $9.2 million in the 2013 second ... quarter of 2014. Revenues for the first six months of ... the first six months of last year. , Gross ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7
... Nov. 14, 2011 Dynex Technologies, Inc., a ... testing easier, more cost-effective, and less labor intensive, ... sample processing system at the MEDICA 2011 – ... November 16 to 19, 2011. The Agility system ...
... Cheyenne Regional Medical Center is expanding its emergency ... AirLife Denver medical helicopter service in Cheyenne. ... and HCA-HealthONE, which operates AIRLIFE Denver. (Photo: ... and sonic green helicopter will be stationed in Cheyenne ...
Cached Medicine Technology:Dynex Technologies to Showcase Agility™ ELISA Processor at MEDICA 2011 - Hall 3, Stand D45-6 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 3
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... risk of heart attack and stroke, particularly if you work ... health officials reported Thursday. But being unemployed might be ... risk include job stress, exposure to air pollution -- like ... Dr. Sara Luckhaupt, from the National Institute for Occupational Safety ...
(Date:8/1/2014)... OR (PRWEB) August 01, 2014 In ... called hydrotherapy – was fundamental to the practice of ... water researcher Sharon Kleyne, water therapy has been relegated ... time when climate change, water shortages, drought and pollution ... diseases, the Sharon Kleyne Hour Power of Water host ...
(Date:8/1/2014)... August 01, 2014 According to the Suspension ... a bodybuilding program for men and women who want to ... of 191 suspension exercises and 27 intense workouts that help ... in its review that the Suspension Revolution 2.0 program provides ... how to create diet plans that help keep ...
(Date:8/1/2014)... Blindness is a reversible ailment these days . ... despite well-meaning efforts, still have a long way to go ... blindness that does not involve any kind of health risk ... takes the “slack” from the mainstream by providing a cure ... , Alternative health specialist Kevin Richardson actually has the ...
Breaking Medicine News(10 mins):Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 3Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 2Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2
... been found by researchers to be more effective than ... borderline personality disorder. This study , which included 38 ... ages of 19 and 51 was conducted by researchers ... differences in rapid mood shift, impulsivity and aggression when ...
... that HRT could reduce risk of heart attack in post ... 1000 women of ages 50 to 69 conducted by the ... study was to determine whether a combination// of oestrogen and ... menopausal women who had already sufferd a previous attack. ...
... observe why surgery may trigger cognitive problems in some ... some older people develop problems with memory and other mental ... Operative Cognitive Dysfunction (POCD).Often relatives will say that the person ... It was assumed, at first, that the anaesthetic was to ...
... skills do home care which is advantageous for ... or chronic obstructive pulmonary disease (COPD) - can be ... A new study from researchers at Barcelona// Hospital, Spain, ... care in the home setting cuts costs, re-admission to ...
... researchers suggests that nurses and junior doctors can both carry ... competence.,There's a shortage of junior doctors in the UK// and ... to take over some of their roles. Researchers in Ireland, ... nurses assess people before surgery. ,They found that ...
... a recent survey, it has been observed that there are ... fasciitis is an inflammation of the band of fibrous tissue ... and the heel.// It causes excruciating pain first thing in ... eases off once you have been on the move for ...
Cached Medicine News:
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... up kit. Includes configured Laptop PC with ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... friendly software. Store/track run data. ... Outstanding uniformity. Advanced control algorithms ...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
Medicine Products: